308 related articles for article (PubMed ID: 24965928)
1. [Current management of antithrombotic treatment in patients with non valvular atrial fibrillation and prior history of stroke or transient ischemic attack].
Masjuán J; Álvarez-Sabín J; Blanco M; de Felipe A; Gil-Núñez A; Gállego-Culleré J; Vivancos J
Rev Neurol; 2014 Jul; 59(1):25-36. PubMed ID: 24965928
[TBL] [Abstract][Full Text] [Related]
2. Use of oral anticoagulants in complex clinical situations with atrial fibrillation.
Gullón A; Sánchez Fuentes D; López-de-Sá E; Martí-Almor J; Barón-Esquivias G; Jiménez López J; Del Mar Contreras Muruaga M; Suárez Fernández C
Med Clin (Barc); 2018 Jun; 150 Suppl 1():8-24. PubMed ID: 30502871
[TBL] [Abstract][Full Text] [Related]
3. Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study.
Yasaka M; Minematsu K; Toyoda K; Yamagami H; Yoshimura S; Nagao T; Mori E; Hirano T; Hamasaki T; Yamaguchi T
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1342-8. PubMed ID: 26987488
[TBL] [Abstract][Full Text] [Related]
4. Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
Ahmad Y; Lip GY
Contrib Nephrol; 2013; 179():81-91. PubMed ID: 23652451
[TBL] [Abstract][Full Text] [Related]
5. [Limitations of anticoagulant therapy].
Martí-Fàbregas J; Delgado-Mederos R; Mateo J
Neurologia; 2012 Mar; 27 Suppl 1():27-32. PubMed ID: 22682207
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of stroke in atrial fibrillation].
Masjuan J
Neurologia; 2012 Mar; 27 Suppl 1():1-3. PubMed ID: 22682203
[No Abstract] [Full Text] [Related]
7. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
8. [Modification of clinical profile of stroke in atrial fibrillation patients. Effect of antithrombotic treatment].
García Escrivà A; López Hernández N; Hernández Lorido R; Oliver Navarrete C; Bustos S; Carneado Ruiz J; Gracia Fleta F; Moltó Jordá JM
Rev Neurol; 2004 Mar 1-15; 38(5):401-5. PubMed ID: 15029514
[TBL] [Abstract][Full Text] [Related]
9. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke.
McCabe DJ; Rakhit RD
J Neurol Neurosurg Psychiatry; 2007 Jan; 78(1):14-24. PubMed ID: 17172564
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation.
Alberts MJ; Eikelboom JW; Hankey GJ
Lancet Neurol; 2012 Dec; 11(12):1066-81. PubMed ID: 23153406
[TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation and cardioembolic stroke.
Ferro JM
Minerva Cardioangiol; 2004 Apr; 52(2):111-24. PubMed ID: 15194993
[TBL] [Abstract][Full Text] [Related]
13. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
[TBL] [Abstract][Full Text] [Related]
14. [Anticoagulation in atrial fibrillation. Strategies in special situations].
Volkmann H; Walter M; Walter C; Vetter S
Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
[TBL] [Abstract][Full Text] [Related]
15. Challenges and misconceptions in the aetiology and management of atrial fibrillation-related strokes.
Thijs V; Butcher K
Eur J Intern Med; 2015 Sep; 26(7):461-7. PubMed ID: 26164438
[TBL] [Abstract][Full Text] [Related]
16. New anticoagulants for atrial fibrillation.
De Caterina R; Kristensen SD; Renda G
J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276
[TBL] [Abstract][Full Text] [Related]
17. [Antithrombotic therapy in patients with first-ever stroke and known non-rheumatic atrial fibrillation].
Gandjour J; Zeindler J; Georgiadis D; Baumgartner RW
Praxis (Bern 1994); 2005 Jan; 94(4):97-104. PubMed ID: 15732803
[TBL] [Abstract][Full Text] [Related]
18. Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
Apostolakis S; Shantsila E; Lip GY; Lane DA
Thromb Haemost; 2009 Nov; 102(5):914-5. PubMed ID: 19888529
[No Abstract] [Full Text] [Related]
19. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
Villines TC; Schnee J; Fraeman K; Siu K; Reynolds MW; Collins J; Schwartzman E
Thromb Haemost; 2015 Nov; 114(6):1290-8. PubMed ID: 26446456
[TBL] [Abstract][Full Text] [Related]
20. Stroke prevention in atrial fibrillation: current status and near-future directions.
De Caterina R; Hylek EM
Am J Med; 2011 Sep; 124(9):793-9. PubMed ID: 21745652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]